Literature DB >> 25142686

Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al.

Tai-Tong Wong1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142686     DOI: 10.1007/s00381-014-2515-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


× No keyword cloud information.
  9 in total

1.  Diffuse brainstem glioma: prognostic factors.

Authors:  Marcos Dellaretti; Nicolas Reyns; Gustavo Touzet; François Dubois; Sebastião Gusmão; Júlio Leonardo Barbosa Pereira; Serge Blond
Journal:  J Neurosurg       Date:  2012-08-31       Impact factor: 5.115

2.  Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.

Authors:  Johannes E Wolff; Michael E Rytting; Tribhawan S Vats; Peter E Zage; Joann L Ater; Shiao Woo; John Kuttesch; Leena Ketonen; Anita Mahajan
Journal:  J Neurooncol       Date:  2011-08-20       Impact factor: 4.130

3.  Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.

Authors:  Amanda M Saratsis; Madhuri Kambhampati; Kendall Snyder; Sridevi Yadavilli; Joseph M Devaney; Brennan Harmon; Jordan Hall; Eric H Raabe; Ping An; Melanie Weingart; Brian R Rood; Suresh N Magge; Tobey J MacDonald; Roger J Packer; Javad Nazarian
Journal:  Acta Neuropathol       Date:  2013-12-03       Impact factor: 17.088

Review 4.  Diffuse brainstem glioma in children: critical review of clinical trials.

Authors:  Darren Hargrave; Ute Bartels; Eric Bouffet
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

5.  Stereotactic biopsy of diffuse pontine lesions in children.

Authors:  Thomas Roujeau; Guilherme Machado; Matthew R Garnett; Catherine Miquel; Stephanie Puget; Birgit Geoerger; Jacques Grill; Nathalie Boddaert; Federico Di Rocco; Michel Zerah; Christian Sainte-Rose
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

Review 6.  The present state of antineoplaston research (1).

Authors:  Stanislaw R Burzynski
Journal:  Integr Cancer Ther       Date:  2004-03       Impact factor: 3.279

7.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.

Authors:  Dong-Anh Khuong-Quang; Pawel Buczkowicz; Patricia Rakopoulos; Xiao-Yang Liu; Adam M Fontebasso; Eric Bouffet; Ute Bartels; Steffen Albrecht; Jeremy Schwartzentruber; Louis Letourneau; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Genevieve Bourret; Pierre Lepage; Adam Fleming; Peter Lichter; Marcel Kool; Andreas von Deimling; Dominik Sturm; Andrey Korshunov; Damien Faury; David T Jones; Jacek Majewski; Stefan M Pfister; Nada Jabado; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2012-06-03       Impact factor: 17.088

8.  Diffuse intrinsic pontine glioma: poised for progress.

Authors:  Katherine E Warren
Journal:  Front Oncol       Date:  2012-12-28       Impact factor: 6.244

9.  The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.

Authors:  Stanislaw R Burzynski; Tomasz J Janicki; Gregory S Burzynski; Ania Marszalek
Journal:  Childs Nerv Syst       Date:  2014-04-10       Impact factor: 1.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.